Estee Lauder Companies (T with ticker code (EL) now have 21 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 244 and 147 and has a mean target at 217.62. Now with the previous closing price of 217.41 this would imply there is a potential upside of .1%. The 50 day moving average now sits at 209.94 and the 200 moving average now moves to 186.95. The company has a market cap of $78,569m. You can visit the company’s website by visiting: http://www.elcompanies.com
The EstÃ©e Lauder Companies Inc. manufactures and markets skin care, makeup, fragrance, and hair care products. The company offers a range of skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, cleansing devices, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising eau de parfum sprays and colognes, as well as lotions, powders, creams, candles, and soaps; and hair care products that include shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company offers its products under EstÃ©e Lauder, Aramis, Clinique, Lab Series, Origins, MÂ·AÂ·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le Labo, Editions de Parfums FrÃ©dÃ©ric Malle, GLAMGLOW, By Kilian, BECCA, Too Faced, RODIN olio lusso, FLIRT!, Kiton, and Tom Ford brands. It also holds license arrangements for Tommy Hilfiger, Donna Karan New York, DKNY, Michael Kors, Ermenegildo Zegna, Dr. Andrew Weil, TOM FORD BEAUTY, AERIN, and Tory Burch brands. The company sells its products through department stores, specialty-multi retailers, upscale perfumeries and pharmacies, and salons and spas; freestanding stores; its own and authorized retailer Websites; third-party online malls; stores in airports and on cruise ships; in-flight and duty-free shops; and self-select outlets. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The EstÃ©e Lauder Companies Inc. has a joint development agreement with Atropos Therapeutics Inc. to discover senomodulators. The company was founded in 1946 and is headquartered in New York, New York.